Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer

World Journal of Surgical Oncology

Volumn 4, Issue , 2006, Pages

  Kouraklis, Gregory ^a   Theocharis, Stamos ^a   Vamvakas, Panayiotis ^a   Vagianos, Costas ^b   Glinavou, Andromahi ^a   Giaginis, Costas ^a   Sioka, Crysoula ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; KI 67 ANTIGEN; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; UNIVARIATE ANALYSIS;

EID: 32144460285     PISSN: 14777819     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7819-4-5     Document Type: Article

References (32)

1. Sherr CJ: Cancer cell cycle. Science 1996, 274:1672-1677.
2. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994, 266:1821-1828.
3. Otori K, Sugiyama K, Fukushima S, Esumi H: Expression of the cyclin DI gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane. Cancer Letters 1999, 140:99-104.
4. Kazanov D, Shapira I, Pick M, Kolker O, Liberman E, Deutsch V: Oncogenic transformation of normal enterocytes by overexpression of cyclin DI. Dig Dis Sci 2003, 48:1251-1261.
5. Resnitzky D, Reed SI: Different roles for cyclins DI and E in regulation of the GI to S transition. Mol Cell Biol 1995, 15:3463-3469.
6. Yu B, Lane ME, Pestell RG, Albanese S, Wadler S: Downregulation of cyclin DI alters cdk-4 and cdk-2 specific phosphorylation of retinoblastoma protein. Mol Cell Biol Res Commun 2000, 3:352-359.
7. Bartkova J, Lukas J, Strauss M, Bartek J: The Prad-1/cyclin DI oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int J Cancer 1994, 58:568-573.
8. Naitoh H, Shibata J, Awaguchi A, Kodama M, Hattori T: Overexpression and localization of cyclin DI mRNA and antigen in esophageal cancer. Am J Pathol 1995, 146:1161-1169.
9. Michalides R, Van Veelen N, Hart A, Loftus B, Wientjens E, Balm A: Overexpression of cyclin DI correlates with recurrence in a group of forty seven operable squamus cell carcinomas of the head and neck. Cancer Res 1995, 55:975-978.
10. Michalides R, Hageman P, Van Tinteren H: A clinico-pathological study on overexpression of cyclin DI and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996, 73:728-734.
11. Stendahl M, Kronbladt A, Ryden L, Emdin S, Benstsson NO, Landberg G: Cyclin DI overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer 2004, 90:1942-1948.
12. van Diest PJ, Michalicles RJ, Jannink L, van derValk P, Peterse HL, de Joug JS, Meijer CJ, Baak JP: Cyclin DI expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 1997, 150:705-711.
13. Palmqvist R, Stenling R, Oberg A, Landberg G: Expression of cyclin DI and retinoblastoma protein in colorectal cancer. Eur J Cancer 1998,34:1575-1581.
14. Arber N, Hibshoosh H, Moss SF: Increased expression of cyclin DI is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996, 110:669-674.
15. Maeda K, Chung YS, Kang SM: Cyclin DI overexpression and prognosis in colorectal adenocarcinoma. Oncology 1998, 55:145-151.
16. Bondi J, Bukholm G, Nesland JM, Bukholm IR: Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin DI in relation to patient outcome in human colon adenocarcinomas. APMIS 2004, 112:49-56.
17. McKay JA, Douglas JJ, Ross VG: Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol 2002, 196:386-393.
18. Holt PR, Mokoulu AD, Distler P, Liu T, Reddy BS: Regional distribution of carcinogen-induced colonic neoplasia in the rat. Nutr Cancer 1996, 25:129-135.
19. Callender T, El Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG: PRAD-I (CCNDI/cyclin DI oncogene amplification in primary head and neck squamus cell carcinoma. Cancer 1994, 74:152-158.
20. Nielsen NH, Emdin SO, Cajander J, Landberg G: Deregulation of cyclin E and DI in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 1997, 14:295-304.
21. Masuda M, Hirakawa N, Nakashima T, Kuratomi Y, Komiyama S: Cyclin DI overexpression in primary hypopharyngeal carcinomas. Cancer 1996,78:390-395.
22. Bukholm IK, Nesland JM: Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 2000, 436:224-228.
23. Holland TA, Elder J, McCloud JM: Subcellular localization of cyclin D1 protein in colorectal; tumours is associated with p21 expression and correlates with patient survival. Int J Cancer 2001, 95:302-308.
24. Kong S, Wei Q, Amos CI: Cyclin DI polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 2001, 93:1106-1108.
25. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M: Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78-85.
26. Cox DR: Regression models and life tables. J R Stat Soc B 1973, 31:1333-1335.
27. McKay JA, Douglas JJ, Ross VG: Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin Cancer Res 2000, 6:1113-1118.
28. Gope R, Christiansen MA, Thorson A: Increased expression of the retinoblastoma gene in human colorectal carcinomas ralative to normal colonic mucosa. J Natl Cancer Inst 1990, 82:310-314.
29. Meling GI, Lothe RA, Borresen AL: Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. BrJ Cancer 1991, 64:474-480.
30. Gope R, Christensen MA, Thorson A: Molecular analysis of retinoblastoma gene in human colorectal carcinomas. In Hereditary Colorectal Cancer Edited by: Utsunomiya J, Lynch, HT. Tokyo Springer; 1990:489-496.
31. Gope R, Gope ML: Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer. Mol Cell Biochem 1992, 110:123-133.
32. Yamamoto H, Soh Jae-Won, Monden T: Paradoxical increase in retinoblastorna protein in colorectal carcinomas may protect cells from apoptosis. Clin Cancer Res 1999, 5:1805-15.